Bariatric Surgery Unit, Bellvitge University Hospital-IDIBELL, FeixaLlarga s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.
Marchesini Institute, Curitiba, Brazil.
Obes Surg. 2020 Sep;30(9):3309-3316. doi: 10.1007/s11695-020-04566-5.
To study weight loss, comorbidity remission, complications, and nutritional deficits after duodenal switch (DS) and single-anastomosis DS with sleeve gastrectomy (SADI-S).
Retrospective review of patients submitted to DS or SADI-S for morbid obesity in a single university hospital.
Four hundred forty patients underwent DS (n = 259) or SADI-S (n = 181). Mean preoperative body mass index (BMI) was 50.8 ± 6.4Kg/m. Mean follow-up was 56.1 ± 37.2 months for DS and 27.2 ± 18.9 months for SADI-S. Global mean excess weight loss was 77.4% at 2 years similar for SADI-S and DS, and 72.1% at 10 years after DS. Although early complications were similar in SADI-S and DS (13.3% vs. 18.9%, p = n.s.), long-term complications and vitamin and micronutrient deficiencies were superior after DS. Rate of comorbidities remission was 85.2% for diabetes, 63.9% for hypertension, 77.6% for dyslipidemia, and 82.1% for sleep apnea, with no differences between both techniques. In patients with initial BMI > 55 kg/m (n = 91), DS achieved higher percentage of BMI < 35 kg/m (80% vs. 50%, p = 0.025) and higher rate of diabetes remission (100% vs. 75%, p = 0050).
DS and SADI-S showed similar weight loss and comorbidity remission rates at 2 years. In patients with initial BMI > 55 kg/m, DS obtained better BMI control at 2 years and better diabetes remission, but more long-term complications and supplementation needs.
研究十二指肠转流术(DS)和单吻合口胃旁路手术(SADI-S)治疗肥胖症的减重效果、合并症缓解情况、并发症和营养缺陷。
对一家大学医院接受 DS 或 SADI-S 治疗的肥胖症患者进行回顾性研究。
440 例患者接受 DS(n=259)或 SADI-S(n=181)治疗。术前平均体重指数(BMI)为 50.8±6.4kg/m。DS 的平均随访时间为 56.1±37.2 个月,SADI-S 的平均随访时间为 27.2±18.9 个月。DS 在 2 年时的全球平均超重减轻率为 77.4%,与 SADI-S 相似,而在 10 年后为 72.1%。尽管 SADI-S 和 DS 的早期并发症相似(13.3% vs. 18.9%,p=0.52),但 DS 的长期并发症和维生素及微量营养素缺乏症的发生率较低。糖尿病、高血压、血脂异常和睡眠呼吸暂停的缓解率分别为 85.2%、63.9%、77.6%和 82.1%,两种技术之间无差异。在初始 BMI>55kg/m(n=91)的患者中,DS 达到 BMI<35kg/m 的百分比更高(80% vs. 50%,p=0.025),糖尿病缓解率更高(100% vs. 75%,p=0.050)。
DS 和 SADI-S 在 2 年内的减重效果和合并症缓解率相似。在初始 BMI>55kg/m 的患者中,DS 在 2 年内获得了更好的 BMI 控制和更高的糖尿病缓解率,但长期并发症和补充需求更多。